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Abstract Lower participation rates in cancer genetic counsel-
ing are observed among different ethnic minorities. The goal
of our study is to gain insight into determinants of Turkish and
Moroccan patients’ participation in breast cancer genetic
counseling and DNA testing, from the point of view of
healthcare professionals and patients. Questionnaire-based
telephone interviews about awareness, perceptions, and rea-
sons for (non-) participation in cancer genetic counseling were
conducted with 78 Dutch breast cancer patients from Turkish
and Moroccan descent. The interviews were held in Arabic,
Berber, Turkish, or Dutch by bilingual research assistants.
Additionally, 14 breast cancer patients participated in one of
two focus group meetings, and two focus groups were held
with 11 healthcare professionals. SPSS and QSR Nvivo were
used to examine the quantitative and qualitative data, respec-
tively. Half of the total group of patients (N = 78) and 79% of
patients eligible for genetic counseling and testing (N = 33)
were aware of the possibility of genetic counseling. The most
important determinants for nonparticipation in genetic
counseling were experienced difficulties in patient-doctor
communication, cultural factors (e.g., social norms), limited
health literacy, limited knowledge of the family cancer history,
and anxiety about cancer. Religious beliefs and knowing per-
sonal and family members’ breast cancer risks were motives
to obtain genetic counseling. Despite the fact that our study
showed that Moroccan and Turkish women reported several
personal motives to obtain genetic counseling and testing
(GCT), patients and healthcare professionals experience sig-
nificant language and health literacy difficulties, which make
it harder to fully access health care such as genetic counseling
and testing.
Keywords Breast cancer . Ethnic minority . Genetic
counseling . Referral
Introduction
Breast cancer is the most frequently occurring cancer among
women worldwide. Breast cancer patients with a young age at
diagnosis (<40 years) or a family history of breast or ovarian
cancer have an increased risk of carrying a BRCA 1/2 gene
mutation. Despite a steadily growing interest in breast cancer
genetic counseling and DNA testing in the past decade, di-
verse ethnic minority groups seem to be underrepresented
within the family cancer clinics (Armstrong et al. 2003;
Armstrong et al. 2005; Forman and Hall 2009; Levy et al.
2011; Sussner et al. 2009; Sussner et al. 2011; van Riel et al.
2012). Recently, we showed in a registry-based study in the
Netherlands that Turkish and Moroccan ethnicity was associ-
ated with a lower participation rate in breast cancer genetic
counseling and testing (GCT), mainly due to a lower referral
rate among patients who were younger than 40 years of age at
diagnosis (Baars et al. 2016). This suggests that migrant
Turkish and Moroccan breast cancer patients, as well as their
family members, are less likely to benefit from the health
benefits of GCT because information about increased cancer
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risks and screening possibilities to facilitate early diagnosis
might not reach them.
In the Netherlands, Turks and Moroccans belong to the
largest migrant groups, with nearly 400,000 inhabitants with
a Turkish background and 375,000 with a Moroccan back-
ground (CBS 2014). Higher relative excess breast cancer mor-
tality in Turkish and Moroccan women points towards possi-
ble inadequate access to health care and treatment, especially
the participation in screening programs (Arnold et al. 2013).
Religious and cultural beliefs seem to influence the utilization
of cancer screening (Rajaram and Rashidi 1999; Rashidi and
Rajaram 2000;Matin and LeBaron 2004; Hasnain et al. 2011),
as well as language (Topal et al. 2015) which is also a known
factor to lead to lower participation rates in GCT in general
(Forman and Hall 2009). To our knowledge, however, deter-
minants of participation in GCT are not known for Moroccan
and Turkish women, specifically. Because of the indications
that these migrant groups are less likely to be reached, our aim
is to study determinants of GCT uptake among Turkish and
Moroccan breast cancer patients.
As with other health interactions, referrals to GCT need to
be a shared decision making (Smets et al. 2007). To fully
understand the perceptions of both patients and healthcare
professionals on the participation in GCT, we will take into
account the broader context, that is, the breast cancer patient’s
experiences with health care as provided by their surgeon and
the communication about cancer in the family. Our research
questions were as follows:What is the awareness about breast
cancer GCT among Moroccan and Turkish breast cancer pa-
tients and what are possible determinants of GCT uptake
among Turkish and Moroccan breast cancer patients from
the point of view of healthcare professionals and patients?
Methods
Study population
The study included Moroccan and Turkish patients who had
been diagnosed with breast cancer between January 2007 and
December 2012 in one of six hospitals in the Utrecht region
and in Amsterdam, the Netherlands.
Procedure
Turkish and Moroccan patients that were identified according
to a name-based approach (Baars et al. 2016; Razum et al.
2001; Spallek et al. 2006, 2009; Hoopman et al. 2009) and
who had been diagnosed with breast cancer (n = 145) were
invited to take part in a study that investigated health care for
Turkish and Moroccan breast cancer patients. To minimize
possible selection bias, genetic counseling was not mentioned
in the recruitment letter. This letter was written in Turkish and
Dutch for the Turkish patients and in Standard Arabic and
Dutch for the Moroccan patients. A research team of four
bilingual research assistants approached and interviewed the
respondents. The research assistants were trained in how to
administer the questionnaire and when to ask further. The
interviews were held between November 2013 and
March 2014 in four languages (Arabic, Berber, Turkish, and
Dutch). Non-response included n = 19 patients who could not
be reached by telephone, n = 16 patients who did not want to
be reminded of the period of having cancer and refrained from
participation, n = 6 patients who were unable to participate
due to illness or age, n = 2 did not have time, n = 10 reported
various other reasons, and n = 14 patients who did not give a
reason why they did not want to participate.
Respondents were generally younger than non-respondents
(mean age at the start of the interviews 49.41 (SD 9.46) versus
54.56 (SD 12.82); p = 0.008)). In total, 78 patients (54%) were
interviewed. Additionally, in October 2014, a sample of seven
of these patients participated in a focus group with Moroccan
patients. In the same month, a focus group of seven Turkish
patients was organized of whom five were recruited through
mediation of an organization for migrant breast cancer patients
and two who had previously participated in our study. The
focus group interview amongMoroccan women was conduct-
ed mainly in the Dutch language, and the Turkish group was
conducted in the Turkish language. In these focus groups,
possible determinants of migrants’ participation in breast can-
cer GCT were further explored within the context of the cul-
tural and religious beliefs within these populations. Possible
determinants were also discussed within two focus groups of
healthcare professionals: a focus group of seven physicians
(surgical oncologists and a radiation oncologist) and a group
of four nurse practitioners from different hospitals that were
held in November and December 2014.
Measures
The telephone interviews were structured using closed and
open questions. Closed questions, with a number of reply
options to be filled in by the interviewer, were used to inquire
about the patients’ socio-demographic characteristics (marital
status, urban or rural family origin, educational level, employ-
ment status, religion) based on Hosper (2007); level of accul-
turation (most common spoken language, most common lan-
guage of internal monolog, ethnic identity and birthplace)
based on Gul et al. and Coronado et al. (Gul and Kolb 2009;
Coronado et al. 2005); family-related issues (family history of
breast and ovarian cancer, family communication about breast
cancer (open question)); and health care (patient satisfaction
with received care and information, communication with their
surgeon). Open questions focusing on possible risk factors for
breast cancer included the role of religion during periods of
illness, awareness of breast cancer GCT, knowledge about
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breast cancer GCT, referral to GCT, and motivators and bar-
riers related to breast cancer GCT. During focus group meet-
ings, several factors that were retrieved from the interviews
and could be related to participation in GCT (family commu-
nication about breast cancer, communication with the physi-
cian, religious point of view on GCT, anxiety about breast
cancer GCT, and other factors) were reflected upon within
the group (Ruff et al. 2005).
Statistical analysis
Descriptive statistics derived from the interviews, tests
to identify differences between groups (χ2 tests and t
tests), and logistic regression analyses were performed
with SPSS. The focus groups were audiotaped and tran-
scribed verbatim. Data resulting from the open questions
and the focus groups were thematically analyzed by
researchers JB and EvR (Ruff et al. 2005; Braun and
Clarke 2006) with the use of QSR Nvivo 10.
During thematic analysis, themes and patterns within the
qualitative data were identified, described, and analyzed
(Braun and Clarke 2006). In addition, an inductive approach
was used in which we acknowledged the ways individuals
make meaning of their experience (Braun and Clarke 2006).
The open questions from the first ten interviews and all four
focus groups were coded by two researchers (JB and EvR)
after which they created a unified coding scheme.
Subsequent interviews were compared with these existing
codes to identify similarities and differences. The codes were
grouped into themes and conceptual categories that were
discussed within the research team.
Results
Socio-demographic variables
Socio-demographic variables of the 78 patients that
were interviewed are shown in Table 1. The Moroccan
patients who participated were, on average, 6 years
younger than the Turkish patients (p = 0.004). Nearly
all women were born in Morocco or Turkey. Of all the
women, both of their parents were born in Morocco
(n = 52) or Turkey (n = 26) (not shown in table).
Most women (64%; n = 50) originated from villages,
6% (n = 5) of the women had either a mother or father
who lived in a village, and 30% (n = 23) reported that
both their parents had lived in a city (not shown in
table).
A large proportion of the Moroccan women (76%) had one
or more children under 18 years of age, and this was higher
than among the Turkish women (32%) (see Table 1). The self-
reported data on family cancer history are presented in
Table 1.
Awareness of breast cancer GCT
Genetic and familial factors were mentioned by 22% of the 78
patients as a possible cause of breast cancer (open question).
Other perceived risk factors for breast cancer were distress and
grief (54%) which could lower the immune system and could
cause breast cancer, lifestyle factors (40%), and Allah’s will
(21%) (not shown in Table).
When asked directly about breast cancer GCT, about
half of the breast cancer patients were aware of this pos-
sibility (see Table 2), mainly because their surgeon had
informed them while asking about breast cancer in their
family. Among Moroccan women in general, awareness
about GCT was higher (60%) compared to that in the
Turkish women (31%; p = 0.016). Univariate analysis
among the total group of migrant patients showed that
awareness was positively associated with having family
members with breast and/or ovarian cancer. A higher pro-
portion of women who reported a first or second degree
family member with breast and/or ovarian cancer was
aware of breast cancer GCT (80%), compared to women
with no family history of breast and/or ovarian cancer
(40%; p = 0.002). Negative associations were found for
age at breast cancer diagnosis. Mean age at diagnosis was
42.10 (SD 7.20) among those who reported to be aware
of breast cancer GCT and 50.54 (SD 9.21) among the
women who reported they had never heard about breast
cancer GCT (p = 0.0001). Furthermore, awareness was
associated with variables related to acculturation (those
who speak mostly Turkish/Moroccan (T/M) versus those
who speak as much T/M as Dutch or mostly Dutch (35
versus 87% aware; p = 0.0001); think mostly in T/M (32
versus 100%; p = 0.0001); feel mostly T/M (37 versus
77%; p = 0.001)) and the use of an interpreter. A lower
proportion of women whose visits to the doctor had been
translated were aware of GCT (34%), as compared to
those who did not use an interpreter (77% aware,
p = 0.0001). When controlled for age at diagnosis in
logistic regression analyses, speaking mostly T/M (OR
0.09; CI 0.02–0.40), feeling mostly T/M (OR 0.21; CI
0.06–0.67) and having an interpreter during the doctor
visits (OR 0.29; CI 0.09–0.87) remained associated with
lower awareness. In all models, age at diagnosis persisted
as a significant predictor of awareness of GCT.
Among the patients who fulfilled the criteria for GCT
based on their self-reported data on family history and
information in their medical record (e.g., age at diagno-
sis, and characteristics of the tumor (n = 33)), 79%
reported they were aware of the possibility to obtain
GCT (83%; n = 19 of 23 Moroccan and 70%; n = 7
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Table 1 Socio-demographic characteristics
Moroccan
N = 52
Turkish
N = 26
Total
N = 78
p value
Age at diagnosisa 44.22 (7.99) 50.51 (10.26) 46.32 (9.24) 0.004
Educational levelb
None 35% (18) 27% (7) 32% (25) -
Primary school 15% (8) 54% (14) 28% (22)
Low 19% (10) 0 (0) 13% (10)
Middle 23% (12) 11% (3) 19% (15)
High 8% (4) 8% (2) 8% (6)
Daytime activity
Paid job 13% (7) 15% (4) 14% (11) -
Disabled, unemployed 25% (13) 42% (11) 31% (24)
Housewife 62% (32) 39% (10) 54% (42)
Retired 0% (0) 4% (1) 1%(1)
Religion
Islam 100% (52) 92% (24) 97% (76) NS
None 0% (0) 8% (2) 3% (2)
Country of birth
Morocco 96% (50) 64% (50) -
Turkey 92% (24) 31% (24)
Netherlands 4% (2) 8% (2) 5% (4)
Acculturation
Speak mostly T/M 67% (35) 77% (20) 71% (55) NS
Think mostly T/M 69% (35) 85% (22) 74% (57) NS
Feel mostly T/M 73% (38) 54% (14) 67% (52) NS
Family characteristics
Presence of
Sisters 98% (51) 96% (25) 97% (76) NS
Children 96% (50) 96% (25) 96% (75)
Daughters 75% (39) 77% (20) 76% (59)
Age of youngest childc
0–18 years 76% (38) 32% (8) 61% (46) 0.0001
≥18 years 24% (12) 68% (17) 39% (29)
Relatives with BC
First degree 10% (5) 19% (5) 13% (10) NS
Do not know 2% (1) (0) 1% (1)
Second degree 19% (10) 12% (3) 17% (13)
Do not know 8% (4) 4% (1) 6% (5)
Relatives with OC
First degree 0 (0) 4% (1) 1% (1) -
Second degree
Yes 2% (1) 0 (0) 1%(1) -
Do not know 18% (9) 4% (1) 13% (11)
Family communication BC
Relatives are aware of patient’s BC 62% (32) 92% (24) 72% (56) 0.004
- no χ2 could be calculated as the conditions of this test could not be fulfilled (>20% of the cells has an expected count <5), T/M Turkish/Moroccan, BC
breast cancer, OC ovarian cancer, NS not significant
a mean (SD)
b Low lower secondary or second stage of basic education, medium (upper) secondary education, high tertiary education
c of those with children
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of 10 Turkish patients) and 64% of the patients eligible for GCT
reported that they had undergoneGCT (61% (n = 14) among 23
Moroccan, and 70% (n = 7) among 10 Turkish patients).
Additionally, three Moroccan patients had received GCT
despite, to our knowledge, not fulfilling the criteria for GCT.
Possible explanations for lower participation: perceptions
of patients and healthcare professionals
The interviews and focus groups among the Turkish and
Moroccan patients revealed several barriers as well as
motives for participation in GCT. The themes that orig-
inated from the patient data are described in the first
column of Table 3. In the second column of the table,
the themes that emerged from the focus groups among
healthcare professionals are presented.
Barriers for participation in GCT
Cultural factors
Some barriers are rooted in the values that characterize
the society of origin. For generations, cancer was a ta-
boo subject in the women’s countries of origin. Their
conversations during the interviews showed that cancer
is seen as a death sentence, which made it hard to talk
about and impacted on family communication.
The cancer taboo was also recognized by the healthcare
professionals (second column of Table 3). They perceived
more secrecy among Turkish and Moroccan women about
their cancer diagnosis. Moreover, the focus groups pointed
towards cultural differences, for example, lack of familiar-
ity of some of the healthcare professionals with migrant
culture of patients. This cultural gap might be a barrier
for patient-physician communication but also for the
recognition of certain characteristics such as correct
estimation of the patient’s age.
The interviews and focus groups for patients showed
that there is limited knowledge of family cancer history
among Turkish and Moroccan women. While living in
the country of origin, (breast) cancer seemed to be less
known or even unknown and was therefore rarely
discussed. Cancer was called Bthe evil disease^ and
was considered taboo. A contributing factor to this
was that, in the villages where the majority of the wom-
en lived previously, visits to the doctor were scarce, and
cancer remained therefore unknown. When finally diag-
nosed, it almost always meant a death sentence. The
social norm was that cancer was not a subject to be
discussed, especially not with children. The women
who migrated seemed to have very little information
about their family history of cancer, if they were aware
of the existence of cancer at all (see quotes 1 and 2).
& Quote 1, INT74, Turkish, aged 55 years at breast cancer
(BC) diagnosis
At the time, cancer didn’t exist yet. At least, we weren’t
familiar with the name. There was no knowledge and no
research was conducted. It was just not mentioned. Only
38 years later when my ex-husband’s uncle was taken to
the hospital in Ankara and died of cancer in his small
intestines, we heard the word ‘cancer’. You had ‘verem’.
The word ‘cancer’ wasn’t known at the time.
& Quote 2, INT75,Moroccan, aged 50 years at BC diagnosis
My father suffered from cancer too, only it was never
mentioned. The disease ‘cancer’ was a totally unknown
disease. Nobody knew what people died of. I only
learned what cancer was all about when I came to the
Netherlands. I saw it on TV. I had never heard of cancer
although I was a grown-up woman when I came to the
Netherlands.
Limited knowledge of family history was mentioned as a
barrier among healthcare professionals as well. The healthcare
professionals reported difficulty in assessing family history
among Moroccan and Turkish patients because these patients
seemed to be less aware of their family history.
Table 2 Awareness and uptake of breast cancer GCT
Moroccan
N = 52
Turkish
N = 26
Total
N = 78
Total patients
meeting
GCT referral
criteria
N = 33
Aware of GCT
Yes: % (N) 59.6% (31)* 30.8% (8)* 50.0% (39) 78.8% (26)
Througha
Surgeon 51.6% (16) 87.5% (7) 59.0% (23) 65.4% (17)
Oncologist 12.9% (4) 0 10.3% (4) 11.5% (3)
Television/media 9.7% (3) 0 7.7% (3) 7.7% (2)
Friends/family 22.6% (7) 12.5% (1) 20.5% (8) 11.5% (3)
Do not know 3.2% (1) 0 2.6% (1) 3.8% (1)
Uptake GCT 32.6% (17) 26.9% (7) 30.8% (24) 63.6% (21)
*p = 0.016
aNo χ2 could be calculated as the conditions of this test could not be
fulfilled (>20% of the cells has an expected count <5)
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The participating nurses suggested that there was
more secrecy about breast cancer among Moroccan
and Turkish women, as if secrecy was a part of their
culture. They referred to situations in which family
members did not want the patient to know they had
cancer.
Contrary to past customs and to the way of life in the
country of origin, it now seems more natural for the migrant
women living in the Netherlands to talk about their own breast
cancer with closer family. A transition in this way of thinking
and the resulting contradictions with their initial beliefs are
shown in quotes 3 and 4.
Table 3 Possible motives and barriers related to participating in GCT
Perspective of patientsa Perspective of healthcare professionalsb
Barriers
Cultural factors
Cancer taboo, cancer as a death sentence Cancer taboo, more secrecy
Lack of familiarity of healthcare professional with migrant culture of
patients
Limited knowledge of family cancer history Limited knowledge of family cancer history
Cancer as an unknown disease More difficulties in accessing family history
Limited information given to children (in country of origin), not informed
when going abroad
Fewer close relationships with second degree family members (Moroccan
women)
Nondisclosure to family members to spare them grief (cancer taboo) Nondisclosure wish of cancer diagnosis by family members
Psychosocial factors
Lacking social support, disagreement of family members, especially
daughters, to obtain GCT
Anxiety of the patient Different mind-set
Patient-physician communication
Language difficulties Language barriers
BPatient not a communication partner^ (translator-physician)
Relying on translator/Bnot sure translation is correct^ (nurses)
Lack of familiarity with health care Limited knowledge about breast cancer and health care in T/M patients
Limited knowledge about breast cancer and illness in general Poorly educated; you have to teach the basics of health and diseases
first
Difficulties in formulating the right questions Other questions of Turkish/Moroccan patients
Being Bnumb^ after disclosure of breast cancer diagnosis
Afraid to ask questions Fewer questions of Turkish/Moroccan patients
Too little time with surgeon Consultations take more time, referral to GCT might be
postponed/delayed and Bforgotten^
Doctor’s role, faith is in their hands
Doctor’s advice taken
Different contact with migrant patients; doctor is seen as the Bhealer^
Motives
Preventive options for oneself In general, positive attitude to GCT observed
Knowing whether family members, especially children, would be at risk;
to gain reassurance
Religious belief; according to Islam/Allah, you have a duty to investigate
in order to become well
Doctor’s advice taken More assertiveness among younger patients
Support of nurse practitioners referring patients to GCT
Making patients aware of the possibilities, Bthey should make GCT
obligatory^
a Based on data from both the interviews and the focus groups with Turkish and Moroccan breast cancer patients
b Based on the focus groups with medical professionals: surgeons, a radiation oncologist, and nurse practitioners
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& Quote 3, INT69, Moroccan, aged 53 at BC diagnosis
In the old days, people didn’t talk about it. In Morocco,
feelings of shame played a major role. My aunt in
Morocco, for instance, had breast cancer. She knew be-
cause she had found a hard lump in her breast that was
sticking out. She would not go and see a doctor as she
felt embarrassed to undress in front of a physician; to
show her bare breasts. [...] In my family there is no more
shame about cancer. It is being discussed like a normal
subject. At the time, when somebody had cancer, it was
not discussed as we thought that the person would only
have a few days left to live. This was caused by a lack of
information. Many people in Morocco suffer from can-
cer while they don’t even know it. I have another aunt in
Morocco who has cancer and everybody knows except
for her, because her children won’t tell her. [....]
Allegedly this is for the benefit of my aunt, as the stress
would be additionally negative.
& Quote 4, INT72, Turkish, aged 37 at BC diagnosis
It is especially difficult because, in our culture, cancer is
always associated with death, and that’s what I think is
the hardest part. It is the first reaction of people. I’m not
talking about my siblings. They are so close to it, they do
understand. They also studied and have their own views
on the matter. But uncles and aunts, who all live in
Turkey, for them it’s a complete disaster, what’s happen-
ing to me. So, that’s really difficult for me.
To demonstrate the extent of the communication about
breast cancer within migrant families, the patients were asked
to identify which family members were aware of the patient’s
own breast cancer diagnosis. Most interviewees reported that
they thought everybody in their family was aware of their
diagnosis. AmongMoroccan patients, members of the extend-
ed family were less likely to be aware of the patient’s breast
cancer (62% reported everybody was aware) compared to
Turkish family members (92%; see Table 1).
The closeness of relationships with second degree family
members plays a role in informing them. When talking
about breast cancer with more distant relatives such as
nieces and aunts, some hesitation could still occur.
Among Moroccan women, the extended family (including
aunts and cousins) seems less close compared to Turkish
families, and sometimes, the relationships are filled with
distrust (see quote 5).
& Quote 5, INT23, Moroccan, aged 38 at BC diagnosis
Within my family, everything is being discussed.
Everything I feel and know about discovering breast
cancer in an early stage, I share with my family. With
other relatives, it’s different. Strangers will only say:
Bwhat a pity ,^ but close relatives, they are happy for
me. You can even be bullied over something that Allah
gave you. That is not very nice.
Saving family members from worry was another reason for
not informing them, which accounted mostly for the closer
family members, such as parents or children. Some women
did not want to tell close family members to spare them the
grief of knowing their beloved one has cancer (quote 6). This
might have to do with the cultural belief that cancer results in
death, which makes it harder to bring up the topic.
& Quote 6, INT10, Moroccan, aged 46 at diagnosis
I find it really difficult [emotionally]. I can’t tell my
mum. She’s old and she’s ill herself. I don’t want to bur-
den her with my disease. She might become even more
ill. My brothers and sisters in Morocco don’t know ei-
ther. That’s because I’m afraid my mum will find out
through my brothers.
Psychosocial factors
Nonparticipation in GCT among those eligible and aware of
the procedure had to do with the lack of social support (dis-
agreement of family members) and the anxiety of the patient
herself. The cancer taboo might play a role here as well.
Relatives involved in the patient’s care, especially daugh-
ters, seem to have a relatively large influence in the patient’s
health-related decision-making, such as participation in GCT.
Some of the patients argued that family members disagreed
with undergoing GCT. Particularly among women who have
language difficulties, daughters are very involved in the pa-
tient’s breast cancer diagnosis and treatment, and when they
do not want to cooperate, theymight have more influence than
among non-Turkish or Moroccan patients. To put this into
perspective, we would also like to mention the example of a
young woman who made an autonomous decision to undergo
GCT despite the reluctance of her brothers.
Anxiety about breast cancer seems to prevent some of the
patients from seeking a referral for cancer GCT. Knowing that
their hereditary cancer will have an impact on the breast can-
cer risk for themselves and their relatives worries them about
the outcomes of GCT, and they do not want to be confronted
with that.
The healthcare professionals noticed a difference in the
mind-set of patients. Women from Dutch origin are usually
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aware of the possible side effects of cancer treatment and look
beyond survival, whereas many Turkish and Moroccan wom-
en focus primarily on survival. This might have to do with the
fact that in the Turkish and Moroccan communities, much
emphasis is placed on the deadliness of cancer. This is perhaps
reflected in their state of mind or attitude during the patient-
physician communication.
Patient-physician communication
Other barriers to referral to GCT lie within the patient-physician
communication. All patients had consulted a surgeon in one of
the six participating hospitals. Although the patient satisfaction
with the care and the information given by the surgeon was
high (respectively, 89.7 and 87.2% reported to be (very) satis-
fied; see Table 4), 68.8% of the patients reported that they did
not always fully understand what the doctor had told them.
Many women had difficulties in processing the infor-
mation from the surgeon (see Tables 3 and 4 and quotes
7–9). Besides the language difficulties, the thematic anal-
ysis showed several factors that might prohibit the migrant
breast cancer patients from becoming fully informed, such
as Black of familiarity with health care^, and Blimited
knowledge about breast cancer and illness in general^.
This might prohibit them from asking the right questions.
Furthermore, the disclosure of the breast cancer diagnosis
seems to keep them in a state of apathy, impeding them
from asking questions (see quote 10).
& Quote 7, INT21, Moroccan, aged 41 at BC diagnosis
If there were things that I didn’t understand, I would ask
for plain examples and then I would know. And some-
times I didn’t understand and would just leave it that way.
& Quote 8, INT12, Moroccan, aged 38 at BC diagnosis
You’re just not used to it; it’s about your body.
Sometimes you’re told things by a doctor and you go
like, yeah, whatever.
& Quote 9, respondent focus group
Because it’s hard for us to express ourselves, we don’t
get enough attention from our GP, nor from the hospi-
tals. They expect a lot from you. While you don’t even
know so much about the disease. If you did know all
about it, you wouldn’t go and see a doctor every time.
& Quote 10, INT43, Moroccan, aged 37 at BC diagnosis
The information was sufficient, but at the time it didn’t
land (I didn’t realise). I felt numb. I saw his lips moving,
but I didn’t hear what he said. I was like a puppet. The
next day I called my GP and he called the hospital and
then gave me more information.
Moreover, there might be a resistance to ask ques-
tions because they suspect the answers might have a
negative consequence (quote 11). Some patients feel
there is lack of time to ask questions to the surgeon.
It is also possible that the doctor is sometimes placed
on a pedestal (see quote 12). In their land of origin,
doctors are high up in the social hierarchy. This position
of the doctor may well prohibit the patients from asking
further questions.
Table 4 Patient-surgeon communication
Moroccan
N = 52
Turkish
N = 26
Total
N = 78
p value
(Very) satisfied with care of surgeon 90.4% (47) 88.5% (23) 89.7% (70) NS
(Very) satisfied with information provided by surgeon 86.5% (45) 88.4% (23) 87.2% (68) NS
Having difficulties understanding surgeona 70.6% (36) 65.4% (17) 68.8% (53) NS
One or more visits being translatedb 71.9% (23/35) 82.6% (19/23) 76.4% (42/55) NS
Had been offered professional translatorb 9.7% (3/31) 30.0% (6/20) 17.7% (9/51) –
Want professional translatorb 25.8% (8/31) 35.0% (7/20) 29.4% (15/51) NS
Trust Dutch doctors most
Trust Turkish/Moroccan doctors most
Same
38.8% (19)
4.1% (2)
57.1% (28)
27.3% (6)
9.1% (2)
63.6% (14)
35.2% (25)
5.6% (4)
59.2% (42)
–
NS not significant
a Having a translator is recorded as having difficulties in understanding the surgeon
b Selection of the women who were (partly) interviewed in the language of origin
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& Quote 11, INT74, Turkish, aged 55 at BC diagnosis
I deliberately didn’t ask in order to avoid more sadness,
insecurity and fear in my life. That’s why I didn’t go into
detail. Patiently, I did what the doctors told me to do.
& Quote 12, INT 32, Turkish, aged 48 at BC diagnosis
She was a very good surgeon. Dr xxx is such a sweet
doctor. You know, I can almost say that I overcame the
disease thanks to my surgeon! Every time I went there,
she welcomed me with a smile and made me forget all
about my disease. She’s a really nice, sweet and funny
lady. I will do doea for her, may Allah give her all she
desires.
Similarly, the healthcare professionals also consider
language differences to be an important barrier. In cases
where an interpreter is present, the patient is often not a
Bcommunication partner^; the conversation about the pa-
tient takes place with the family translator. Thus, the
migrant patient is often not directly involved in the
communication, because the conversation is between
the children/husband/interpreter and the doctor.
Nurses agreed that there were many language difficulties
and they were not sure if everything was translated correctly.
Occasionally, and more so in the past, the family member who
was translating (on most occasions the husband or a son/
daughter) did not want the patient to know she had breast
cancer. It was difficult to know how to deal with that because
the medical staff wanted to respect the patient’s culture as
well.
Besides language problems and cultural differences (e.g.,
social norms about cancer), medical staff also noticed differ-
ences in health education. The physicians have to educate
many women about basic aspects of the body and the health
system. It was observed that non-Turkish or Moroccan wom-
en were askingmore frequent and different kinds of questions,
for example, about side effects of chemotherapy or about the
risks for their children to develop cancer. The Moroccan and
Turkish women seemed to be less familiar with breast cancer
and had a poorer level of education in general.
According to the healthcare professionals, especially the
surgeons, a consultation with Moroccan and Turkish women
takes more time due to the educational differences and lack of
familiarity with health in general. As a result, it is possible that
the subject of GCT is postponed.When postponed, it could be
more likely that the subject is forgotten to be brought up at a
later date.
Doctors feel they have a different role as Bhealer^ with
migrant patients compared to non-migrant patients, and that,
the former look up to the doctor. This seems to influence their
interaction with the patient (see quotes 13 and 14).
& Quote 13, focus group, surgeon
Well, let me put it like this, I’ve always felt that as a
doctor, you are … you have the role of a magician.
Because many people have a tendency to trust you im-
mediately and completely and that you take care of them
and they want to hear they’re doing well, or that it’s not
so bad. So you do have, you know, a different role as a
doctor, I think, than with the native group, the Dutch
group. In a way, you’re more... I’d call it a magician,
you’re assigned a role like that. What you say is imper-
ative. Whilst the native group, they’re more critical and
often say, ‘Well ... is that right?’.
& Quote 14, fragment from the focus group of nurse
practitioners
R1: I remember when one of our surgeons left and there
were some of those foreign women who really adored
him and went, BOh doctor…^ They cried because he
left. Apparently, they really become attached to a per-
son. And that’s quite exceptional […].
R1: Yeah, like somebody helps me to survive, so to
speak.
R3: Yes, but imagine you wind up in a foreign hospital,
where you don’t know the language. Well, you’d cling to
anyone who’s being nice to you.
R1: Yes, that’s true. Just like with this category, where
sometimes you can’t grasp it all, and it’s all the more
important to be very nice to them.
R3: Yeah, well, I recognize that.
Motives for participation in GCT
Several factors seem to stimulate participation in GCT, such as
the preventive options for oneself and the fact that information
is obtained about children and sisters’ breast cancer risks.
Although some women perceived their breast cancer diag-
nosis as a test of God, religious beliefs do not seem to prohibit
the women in our sample from obtaining GCT. Rather, it
could be seen as a stimulus. When questioned in the focus
groups, the women suggested that because Allah gave them
the disease, they had a duty to investigate in order to recover,
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which might actually motivate women to pursue GCT (see
quote 15). Another trigger to undergo GCT was a doctor
who told them to do so. The importance of awareness of the
possibilities of GCTamong all women and even making GCT
obligatory were mentioned as well (see Table 3).
& Quote 15, fragment from the focus group of Turkish
patients
S4: From the point of view of Islam, it is important to
look for opportunities [about genetic counseling]. You
may say, ‘Well, I’m ill. I’ll do nothing. I won’t undergo
examinations and testing’. The Islam faith tells that you
have to get examined. There is a saying in Turkish ...
S6: You should not stay put, but you must continue to
investigate.
Although many barriers might prohibit participation
in GCT directly or indirectly, the healthcare profes-
sionals believe that there seems to be turning point.
When compared with diagnoses from 20 years ago,
Turkish and Moroccan patients, especially the younger
women, have become more assertive and breast cancer
seems to be less of a taboo. In general, when asked
directly about the possibilities of GCT, there seems to
be a positive attitude towards it.
In the focus group of healthcare professionals, a positive
Btask^ in the checkup for referral was seen to by nurse prac-
titioners. The limited time of the physician was considered a
barrier to referring GCT as it might be overlooked; however,
the reminders of nurse practitioners were found to be very
useful, according to the physicians.
Discussion
Our study showed that half of the total group of patients was
interviewed, and nearly 80% of eligible patients were aware of
GCT. Of these, approximately 60% of eligible patients had
actually obtained GCT. Moroccan and Turkish patients them-
selves, as well as the healthcare professionals, identified sig-
nificant language and health literacy difficulties. Among these
patients are mainly first-generation migrants with a low level
of education; these difficulties were observed in the patient-
doctor communication. This made it harder for them to fully
access genetic counseling and testing. Moreover, cultural fac-
tors (e.g., social norms and customs), limited knowledge of
the family cancer history, and anxiety about cancer were de-
terminants of nonparticipation.
The first step to participation in GCT is having access to a
provider (Forman and Hall 2009). In our study, all
respondents were breast cancer patients and thus had access
to a physician that could refer them to GCT. In the
Netherlands, physicians are according to the Medical
Treatment Act (WGBO) obliged to inform patients fully about
their diagnosis, treatment, and prognosis. Geographic and
economic barriers to GCT as reported by others (Forman
and Hall 2009) are less likely in a small and densely
populated country such as the Netherlands, where the costs
of genetic counseling and DNA testing are covered by health
insurance with the exception of the obligatory deductible
excess of minimally 385 euros per year, which may or may
not have already been used for a particular patient. Similar
barriers to GCT as mentioned by Forman and Hall (2009)
found among Turkish and Moroccan patients had to do with
awareness of GCT, risk awareness of having hereditary can-
cer, and language and cultural factors. Our data shows that the
cancer taboo as a cultural factor is still present in Turkish and
Moroccan communities. It hinders the inter-family communi-
cation about the family cancer history, resulting in an inaccu-
rate risk awareness by the both the patient and the physician.
These findings agree with others who have studied barriers to
GCT among other ethnic groups (Sussner et al. 2009;
Vadaparampil et al. 2006); acculturation seems to play a role
in the referral process among Turkish and Moroccan women.
We have shown that awareness of the possibility to obtain
GCT was associated with variables relating to acculturation,
reflecting part of the language problems. Patient-doctor com-
munication is limited by language and cultural barriers (e.g.,
attitude towards physician), hindering referral to GCT.
The health care system in the Netherlands is built upon
increased patient assertiveness. This is also the case for
GCT, where patients are usually referred by their physician
(surgeon or general practitioner), but the initiative to undergo
GCT may also come from the patient who, for example, asks
questions to the doctor because of her family cancer history
(van Riel et al. 2012). The limited knowledge of family cancer
history among Turkish and Moroccan patients prevents them
from voicing their concerns. Furthermore, the limited aware-
ness of GCT makes it impossible for some of the women to
ask about the possibility of obtaining GCT. Moreover, our
results suggest that a lower level of health literacy, defined
as Bthe degree to which individuals can obtain, process, un-
derstand, and communicate about health-related information
needed to make informed health decisions^ (Berkman et al.
2010), is an important determinant of the lower participation
rate of Moroccan and Turkish breast cancer patients. The cul-
tural background of the women, especially their experiences
with doctors, their limited knowledge of cancer, and language
difficulties, may influence the way in which individuals inter-
act with clinicians, the health care system, and their health-
related goals as stated by Berkman et al. (2010). In their coun-
try of origin, doctors are high in the social hierarchy. Also, in
the Netherlands, doctors are usually highly revered bymigrant
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women; they put their faith in the hands of the physician. In
this way, these women can remain sub-assertive and obedient,
instead of taking an assertive role.
Although others (Forman and Hall 2009; Thompson et al.
2003) found that an expressed belief in divine order or pur-
pose was more common among minorities and hypothesized
that spirituality may also mold behaviors related to genetic
risk and cancer prevention, we found that religion could also
be a motivating factor to participate in GCT. Because breast
cancer is considered a test, it is the women’s duty to grasp
every possibility to become well (Thompson et al. 2003).
Knowing one’s own risk and that of the family members
was an important motivation to obtain GCTas well. Our study
showed that there are several personal motives to obtain GCT
when potential barriers have been overcome.
Limitations
The non-response analysis showed that the respondents were
younger than the non-respondents, and one of the reasons for
rejecting the telephone interview was that the patients did not
want to be reminded of the period of time when they had
breast cancer. Although we had interviewees who argued that
it was difficult for them to talk about breast cancer, our sample
might be biased towards those for whom breast cancer was
less of a taboo and those who were more familiar with GCT.
The telephone interviews were done by a research team of
four bilingual research assistants. Having different individuals
taking interviews risks leading to variation in the approach
and follow-up questions. By supporting them closely (initial
training, reflection on results, and personal follow-up meet-
ings), we tried to minimize the possibility of information bias.
Practice implications
Our study showed differences between Turkish and Moroccan
patients in disclosing the patient’s breast cancer to family mem-
bers. Distant members of Moroccan families such as aunts and
uncles were less likely to be aware. This should be kept in mind
when accessing family cancer history. Because of the difficul-
ties in disclosing the breast cancer diagnosis to family mem-
bers, healthcare professionals could be trained in how patients
could learn skills to disclose Bbad news^ information to their
family members, in this way helping them to spread health
education messages and to enhance genetic counseling.
In case of a moderately or highly increased breast cancer
risk, periodic surveillance of those with an increased risk is
recommended and/or preventive surgery for carriers of a
BRCA1/2 gene mutation (Chen and Parmigiani 2007). To
minimalize health disparities, education about the process of
referral to GCTmight help to empower migrant women to ask
questions about the procedure and to enhance shared decision-
making. Moreover, physicians should be aware of their
limited communication capabilities, as well as interaction with
migrant patients. Future studies should focus on the possibility
of personalized training for physicians on the discussion and
awareness of cancer genetic counseling with migrant breast
cancer patients in order to guarantee equal access to breast
genetic counseling for all.
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